Splenectomy exacerbates lung injury after ischemic acute kidney injury in mice. 2011

Ana Andrés-Hernando, and Christopher Altmann, and Nilesh Ahuja, and Miguel A Lanaspa, and Raphael Nemenoff, and Zhibin He, and Takuji Ishimoto, and Pete A Simpson, and Mary C Weiser-Evans, and Jasna Bacalja, and Sarah Faubel
Department of Medicine, Division of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA.

Patients with acute kidney injury (AKI) have increased serum proinflammatory cytokines and an increased occurrence of respiratory complications. The aim of the present study was to examine the effect of renal and extrarenal cytokine production on AKI-mediated lung injury in mice. C57Bl/6 mice underwent sham surgery, splenectomy, ischemic AKI, or ischemic AKI with splenectomy and kidney, spleen, and liver cytokine mRNA, serum cytokines, and lung injury were examined. The proinflammatory cytokines IL-6, CXCL1, IL-1β, and TNF-α were increased in the kidney, spleen, and liver within 6 h of ischemic AKI. Since splenic proinflammatory cytokines were increased, we hypothesized that splenectomy would protect against AKI-mediated lung injury. On the contrary, splenectomy with AKI resulted in increased serum IL-6 and worse lung injury as judged by increased lung capillary leak, higher lung myeloperoxidase activity, and higher lung CXCL1 vs. AKI alone. Splenectomy itself was not associated with increased serum IL-6 or lung injury vs. sham. To investigate the mechanism of the increased proinflammatory response, splenic production of the anti-inflammatory cytokine IL-10 was determined and was markedly upregulated. To confirm that splenic IL-10 downregulates the proinflammatory response of AKI, IL-10 was administered to splenectomized mice with AKI, which reduced serum IL-6 and improved lung injury. Our data demonstrate that AKI in the absence of a counter anti-inflammatory response by splenic IL-10 production results in an exuberant proinflammatory response and lung injury.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D013156 Splenectomy Surgical procedure involving either partial or entire removal of the spleen. Splenectomies
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries

Related Publications

Ana Andrés-Hernando, and Christopher Altmann, and Nilesh Ahuja, and Miguel A Lanaspa, and Raphael Nemenoff, and Zhibin He, and Takuji Ishimoto, and Pete A Simpson, and Mary C Weiser-Evans, and Jasna Bacalja, and Sarah Faubel
August 2018, Journal of immunology (Baltimore, Md. : 1950),
Ana Andrés-Hernando, and Christopher Altmann, and Nilesh Ahuja, and Miguel A Lanaspa, and Raphael Nemenoff, and Zhibin He, and Takuji Ishimoto, and Pete A Simpson, and Mary C Weiser-Evans, and Jasna Bacalja, and Sarah Faubel
March 2022, Kidney international,
Ana Andrés-Hernando, and Christopher Altmann, and Nilesh Ahuja, and Miguel A Lanaspa, and Raphael Nemenoff, and Zhibin He, and Takuji Ishimoto, and Pete A Simpson, and Mary C Weiser-Evans, and Jasna Bacalja, and Sarah Faubel
September 2013, American journal of respiratory cell and molecular biology,
Ana Andrés-Hernando, and Christopher Altmann, and Nilesh Ahuja, and Miguel A Lanaspa, and Raphael Nemenoff, and Zhibin He, and Takuji Ishimoto, and Pete A Simpson, and Mary C Weiser-Evans, and Jasna Bacalja, and Sarah Faubel
March 2022, Endocrine journal,
Ana Andrés-Hernando, and Christopher Altmann, and Nilesh Ahuja, and Miguel A Lanaspa, and Raphael Nemenoff, and Zhibin He, and Takuji Ishimoto, and Pete A Simpson, and Mary C Weiser-Evans, and Jasna Bacalja, and Sarah Faubel
January 2016, PloS one,
Ana Andrés-Hernando, and Christopher Altmann, and Nilesh Ahuja, and Miguel A Lanaspa, and Raphael Nemenoff, and Zhibin He, and Takuji Ishimoto, and Pete A Simpson, and Mary C Weiser-Evans, and Jasna Bacalja, and Sarah Faubel
July 2022, Molecular medicine (Cambridge, Mass.),
Ana Andrés-Hernando, and Christopher Altmann, and Nilesh Ahuja, and Miguel A Lanaspa, and Raphael Nemenoff, and Zhibin He, and Takuji Ishimoto, and Pete A Simpson, and Mary C Weiser-Evans, and Jasna Bacalja, and Sarah Faubel
August 2012, Shock (Augusta, Ga.),
Ana Andrés-Hernando, and Christopher Altmann, and Nilesh Ahuja, and Miguel A Lanaspa, and Raphael Nemenoff, and Zhibin He, and Takuji Ishimoto, and Pete A Simpson, and Mary C Weiser-Evans, and Jasna Bacalja, and Sarah Faubel
January 2017, International journal of biological sciences,
Ana Andrés-Hernando, and Christopher Altmann, and Nilesh Ahuja, and Miguel A Lanaspa, and Raphael Nemenoff, and Zhibin He, and Takuji Ishimoto, and Pete A Simpson, and Mary C Weiser-Evans, and Jasna Bacalja, and Sarah Faubel
July 2011, American journal of physiology. Renal physiology,
Ana Andrés-Hernando, and Christopher Altmann, and Nilesh Ahuja, and Miguel A Lanaspa, and Raphael Nemenoff, and Zhibin He, and Takuji Ishimoto, and Pete A Simpson, and Mary C Weiser-Evans, and Jasna Bacalja, and Sarah Faubel
January 2016, PloS one,
Copied contents to your clipboard!